ArticleTranslational cancer research2020

Inhibition of osteopontin overcomes acquired resistance to afatinib in EGFR-mutant non-small-cell lung cancer.

Hongye Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.